Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
If the RPS are held by ZCC and dividends are paid to Zenith Epigenitics ZEN, who decides when ZEN shareholders get paid a dividend?